Helus Pharma (NASDAQ:HELP) reported quarterly earnings results on February 13, 2026 that fell short of analyst expectations. The company reported earnings per share of $-1.00,…
Helus Pharma (NASDAQ:HELP) reported quarterly earnings results on February 13, 2026 that fell short of analyst expectations.
The company reported earnings per share of $-1.00, missing the consensus estimate of $-0.80 by $0.20 per share. Revenue came in at , meeting the estimate of .
Helus Pharma's stock moved following the earnings release.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · HELP
Keep reading
